Oligonucleotide Therapeutics Society Revenue

Research Services • San Diego, California, United States • 1-10 Employees

Oligonucleotide Therapeutics Society revenue & valuation

Annual revenue	$3,226,861
Revenue per employee	$646,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$10,400,000
Total funding	No funding

Key Contact at Oligonucleotide Therapeutics Society

Hassan Fakih

Member Board of Directors

Company overview

Headquarters	4377 NEWPORT AVE, San Diego, California 92107, US
Phone number	+16196337467
Website	oligotherapeutics.org
NAICS	5417
SIC	862
Keywords	Non-Profit, Sirna, Antisense, Aptamers, Immunomodulatory, Micro/Non-Coding Rna Research, Oligonucleotide-Based Disciplines
Founded	2004
Employees	1-10
Socials

About Oligonucleotide Therapeutics Society

Incorporated in 2004 as a 501(c)6 nonprofit and registered with the U.S. government, the Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics The OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities,very much like the impact that antibodies had on human therapeutics over the last decade. The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine. It is the intense scientific exchange between attendees during our annual meetings that sets the stage for groundbreaking new ideas.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Oligonucleotide Therapeutics Society has never raised funding before.

Oligonucleotide Therapeutics Society Tech Stack

Discover the technologies and tools that power Oligonucleotide Therapeutics Society's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

GoDaddy

Hosting

Nginx

Reverse proxies

HTTP/3

Miscellaneous

Sucuri

CDN

MailChimp

Frequently asked questions

Oligonucleotide Therapeutics Society is located in San Diego, California, US.

You can reach Oligonucleotide Therapeutics Society at +16196337467.

Oligonucleotide Therapeutics Society generates an estimated annual revenue of $3,226,861. This revenue figure reflects the company's market position and business performance in its industry.

Oligonucleotide Therapeutics Society has an estimated valuation of $10,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Oligonucleotide Therapeutics Society was founded in 2004, making it 22 years old. The company has established itself as a significant player in its industry over this time.

Oligonucleotide Therapeutics Society has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Oligonucleotide Therapeutics Society

Hassan Fakih

Member Board of Directors

4.8

40,000 users